Clinical Trials Using Zafirlukast

Clinical trials are research studies that involve people. The clinical trials on this list are studying Zafirlukast. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Zafirlukast for the Treatment of Tumor-Marker Only Relapsed Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    This phase II trial investigates how well zafirlukast works in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has an elevated tumor marker as the only indicator that cancer has come back (tumor-marker only relapsed). Zafirlukast is a drug used to prevent and treat symptoms of asthma and also demonstrates the ability to prevent tumor activity. Giving zafirlukast may reduce the tumor marker CA-125 as well as the tendency to form blood clots.
    Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts